Curevac N.V. (NQ: CVAC )
3.285
+0.055
(+1.70%)
Streaming Delayed Price
Updated: 11:53 AM EDT, Aug 21, 2024
Add to My Watchlist
All News about Curevac N.V.
![](https://g.foolcdn.com/editorial/images/632358/moderna_and_pfizer_may_benefit_from_this_rivals_bad_news.jpg)
![](https://g.foolcdn.com/editorial/images/632356/can_curevac_recover_after_its_vaccine_setback.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
30 Stocks Moving In Thursday's Mid-Day Session
July 01, 2021
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_236.png)
58 Biggest Movers From Yesterday
July 02, 2021
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_397.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_76.jpg)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/peek_into_the_marketnew_208.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/covid-19_vaccine__image_by_torstensimon_from_pixabay_11.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png)
From CureVac
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png)
From CureVac
Via AccessWire
![](https://media.bespokepremium.com/uploads/2021/06/062921-RIY-1.png)
![](https://g.foolcdn.com/editorial/images/631864/group-of-businesspeople-looking-frustrated-at-a-desk.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png)
![](https://g.foolcdn.com/editorial/images/631407/gettyimages-1239286866.jpg)
![](https://g.foolcdn.com/editorial/images/631218/covid-vaccine-with-dollar-sign.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/covid-19_vaccine_photo_by_daniel_schludi_on_unsplash_13.jpg)
![](https://g.foolcdn.com/editorial/images/631060/gettyimages-1313915798.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_346.jpg)
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
June 20, 2021
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_227.png)
![](https://www.investors.com/wp-content/uploads/2018/04/stock-Federal-Reserve-06-adobe.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_388.png)
![](https://g.foolcdn.com/editorial/images/631087/gettyimages-scientist_computer_others-in-background.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_226.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/diana-polekhina-bufafc4l8v0-unsplash_0.jpg)
Tesla Partner CureVac Says Will Find 'Sweet Spot' For COVID-19 Vaccine Despite Disappointing Data
June 18, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.